Insider Trading February 23, 2026

Timken Director Disposes $1.06M in Shares as Stock Trades Near Yearly High

Director Kyle Richard G reduces holding amid high share price and recent strong quarterly results

By Derek Hwang TKR
Timken Director Disposes $1.06M in Shares as Stock Trades Near Yearly High
TKR

A Timken Co director sold 10,000 shares on February 19, 2026, for roughly $1.06 million as the stock approached its 52-week peak. The transaction, reported on a Form 4, followed robust fourth-quarter results and recent analyst price-target revisions, while third-party analysis flags the stock as overvalued relative to its fair value.

Key Points

  • Director Kyle Richard G sold 10,000 Timken shares on February 19, 2026, for about $1.06 million at prices between $106.37 and $106.95 with a $106.72 weighted average.
  • Timken reported Q4 2025 EPS of $1.14 and revenue of $1.11 billion, both above expectations; the board declared a $0.35 quarterly dividend, its 415th consecutive quarter.
  • Analyst moves followed the results - DA Davidson raised its price target to $108 (Neutral) citing 5.6% organic growth and a flattish Q1 2026 outlook, while KeyBanc upgraded to Overweight with a $130 target, citing expectations for an industrial cycle inflection and potential value creation under CEO Lucian Boldea.

Timken Co (NYSE:TKR) director Kyle Richard G executed the sale of 10,000 common shares on February 19, 2026, in multiple transactions that generated about $1.06 million in proceeds. Trade prices in the series ranged from $106.37 to $106.95 per share, according to a Form 4 filing with the Securities and Exchange Commission.

The filing records a weighted average sale price of $106.72. After completing these trades, Kyle directly holds 263,272 shares of Timken Co.

The timing of the disposal coincides with the stock trading close to its 52-week high of $111.39, having risen 92% from its 52-week low of $56.20. Publicly available analysis from InvestingPro indicates the stock is considered overvalued versus its assessed Fair Value. Additional market metrics cited include a year-to-date return of 28% and a price-to-earnings ratio of 26.

Separately, Timken reported fourth-quarter 2025 financial results that exceeded consensus forecasts. Earnings per share for the quarter were $1.14, above the projected $1.09, while revenue reached $1.11 billion versus expected revenue of $1.07 billion. The board also approved a quarterly cash dividend of $0.35 per share, marking the company’s 415th consecutive quarterly dividend payment.

Following the earnings announcement, a pair of analysts revised their outlooks. DA Davidson increased its price target on Timken to $108 from $86 while maintaining a Neutral rating; the firm cited 5.6% organic growth in the reported quarter and described the company’s outlook for the first quarter of 2026 as flattish. KeyBanc Capital Markets upgraded the stock to Overweight and set a $130 price target, pointing to an anticipated industrial cycle inflection and possible value creation under new CEO Lucian Boldea.

Investors seeking expanded valuation and strategy commentary can consult the Pro Research Report indicated by InvestingPro for further insights and additional InvestingPro Tips. The Form 4 disclosure and the company’s published quarterly results provide the primary sources for the transactions and performance figures reported here.


Context and market signals

The insider sale is documented formally through the SEC filing and occurs against a backdrop of stronger-than-expected quarterly performance and active analyst reassessments. While the director’s remaining stake remains material, the reported trades reduce his direct holding by the 10,000 shares sold on February 19, 2026.

What remains publicly available

Public filings list the transaction prices, weighted average price, and post-sale ownership. Third-party valuation commentary and analyst notes referenced in this report reflect market participants’ assessments that have been published alongside company disclosures.

Risks

  • Valuation concern - InvestingPro analysis indicates the stock is currently overvalued relative to its Fair Value, which could affect investor returns if market sentiment changes. Impacted sectors: equities and industrials.
  • Operational outlook uncertainty - DA Davidson describes the company’s immediate outlook as flattish for Q1 2026, introducing near-term execution risk for Timken’s industrial operations. Impacted sectors: manufacturing and industrials.

More from Insider Trading

Biodesix CFO Disposes of 535 Shares as Company Posts Revenue Gains and EBITDA Profitability Feb 23, 2026 Biodesix CCO Sells Shares to Cover RSU Taxes After Recent Option Exercise Feb 23, 2026 Biodesix CDO Sells $7,103 in Stock as Company Posts Strong Preliminary Results Feb 23, 2026 Ameris Bancorp Strategy Chief Withholds Shares to Cover Taxes After $550k Sale Feb 23, 2026 Samsara Legal Chief Sells $125,611 in Class A Shares as Stock Nears 52-Week Low Feb 23, 2026